Compare FLL & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | RCEL |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.7M | 102.5M |
| IPO Year | 1993 | N/A |
| Metric | FLL | RCEL |
|---|---|---|
| Price | $2.33 | $4.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.00 | ★ $7.17 |
| AVG Volume (30 Days) | 149.8K | ★ 225.6K |
| Earning Date | 03-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $299,916,000.00 | $72,401,000.00 |
| Revenue This Year | $4.87 | $13.61 |
| Revenue Next Year | $7.48 | $19.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.45 | ★ 20.59 |
| 52 Week Low | $2.25 | $3.22 |
| 52 Week High | $5.59 | $11.25 |
| Indicator | FLL | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 34.68 | 68.80 |
| Support Level | $2.36 | $4.21 |
| Resistance Level | $2.53 | $4.57 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 5.56 | 89.47 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.